Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT00315913

Trial of Oxytocin Alone Versus Oxytocin and Propranolol for the Treatment of Abnormal Labor

Placebo-Controlled Randomized Trial of Oxytocin Alone Versus Oxytocin and Propranolol for the Treatment of Dysfunctional Labor

Status
Withdrawn
Phase
Phase 2
Study type
Interventional
Enrollment
0 (actual)
Sponsor
University of California, Irvine · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine whether propranolol is better than oxytocin for the treatment of labor abnormalities. The endpoint is the rate of vaginal delivery experienced by women receiving prolonged oxytocin versus propranolol.

Detailed description

This trial was designed to test if propranolo can reduce the c section rate for dysfuctional labor. Due to stringent inclution and exclusion criteria and low enrollment the study was closed.

Conditions

Interventions

TypeNameDescription
DRUGPropranololIV Propranolol 1mg/min for a total of 2 minutes. Total dose 2mg
OTHERIV PlaceboIV Saline Solution

Timeline

Start date
2004-01-01
Primary completion
2008-03-01
Completion
2008-03-01
First posted
2006-04-19
Last updated
2019-02-27

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00315913. Inclusion in this directory is not an endorsement.